克罗恩病回结肠切除术后孤立吻合口溃疡与轻度回肠复发疾病进展风险差异
这项回顾性单中心研究纳入207例克罗恩病回结肠切除术后12个月内行回结肠镜检查的患者,比较改良Rutgeert评分i2a(吻合口孤立病变)与i2b(新末端回肠>5处阿弗他病变)相对于i0-i1的内镜下进展和再手术风险。结果显示i2b与内镜下进展(HR 6.22)和再手术(HR 3.64)风险升高相关,而i2a无显著升高。
要点
- i2b病变较i0-i1内镜下进展风险显著升高(HR 6.22,95%CI 2.38-16.2,P=.0008)。
- i2a病变较i0-i1内镜下进展风险无显著差异(HR 2.30,95%CI .80-6.66,P=.12)。
- i2b较i0-i1再手术风险升高(HR 3.64,95%CI 1.10-12.1,P=.034),i2a无显著升高(HR 1.43,95%CI .35-5.77,P=.62)。
核心结论
- 克罗恩病切除术后1年内结肠镜检查发现局限于回结肠吻合口的病变(RS i2a)与进展为更严重疾病的风险无显著升高相关,而新回肠病变(RS i2b)则相关。
- 需要前瞻性研究来证实这些发现。
研究设计与样本
- 回顾性单中心研究,纳入2004年至2014年间所有符合条件的克罗恩病患者,这些患者在回结肠切除加一期吻合术后≤12个月行回结肠镜检查,且索引内镜评估后有>1年记录的临床随访。
- 共207例患者(中位年龄36岁,四分位距26-48)在回结肠切除术后≤12个月行回结肠镜检查。
主要发现
- 索引结肠镜检查时,95例(45.9%)RS为i0,31例(14.9%)为i1,40例(19.3%)为i2a,25例(12.1%)为i2b,10例(4.8%)为i3,6例(2.9%)为i4。
- 191例RS为i0至i2的患者纳入再手术分析,149例有第二次内镜评估的患者纳入内镜下疾病进展主要结局分析。
- i2b病变较i0或i1内镜下进展风险显著更高(HR 6.22;95%CI 2.38-16.2;P=.0008);i2a较i0或i1内镜下进展率无显著升高(HR 2.30;95%CI .80-6.66;P=.12)。
- i2b病变较i0或i1再手术风险更高(HR 3.64;95%CI 1.10-12.1;P=.034);i2a病变再手术风险无显著升高(HR 1.43;95%CI .35-5.77;P=.62)。
关键数值与推荐
- 改良Rutgeert评分将i2细分为局限于吻合口的病变(i2a)或新末端回肠>5处阿弗他病变(i2b)。
- 内镜下进展预定义为后续结肠镜检查中RS进展至i3或i4;再手术干预定义为既往回结肠吻合口的再切除或狭窄成形术。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文为回顾性单中心研究。
- 需要前瞻性研究来证实这些发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: It is standard of care to perform ileocolonoscopy within a year of ileocolonic resection for Crohn's disease (CD) and to guide management decisions based on the Rutgeert score (RS). The modified RS subdivides i2 into lesions confined to the anastomosis (i2a) or >5 aphthous lesions in the neoterminal ileum (i2b). There is uncertainty, however, if i2a lesions incur an increased risk of disease recurrence. The primary aim of this study was to compare the rates of endoscopic progression between i2a and i2b when compared with i0-i1. METHODS: This was a retrospective, single-center study including patients with CD who had an ileocolonoscopy ≤12 months after ileocolonic resection with primary anastomosis and who had >1 year of documented clinical follow-up after the index endoscopic evaluation. All consecutive eligible patients between 2004 and 2014 were included in the study. Demographic, disease, and treatment data were collected. Patients with i3 or i4 at index colonoscopy were excluded from further analyses. Outcomes included endoscopic progression and recurrent surgery. For patients with RS of i0 to i2, endoscopic progression was predefined as progression of the RS in subsequent colonoscopies to i3 or i4. Recurrent surgical interventions were defined as re-resection or stricturoplasty of the previous ileocolonic anastomosis. RESULTS: Two hundred seven CD patients (median age, 36 years [interquartile range, 26-48]) had an ileocolonoscopy ≤12 months after ileocolonic resection. At index colonoscopy, 95 patients (45.9%) had an RS of i0, 31 (14.9%) i1, 40 (19.3%) i2a, 25 (12.1%) i2b, 10 (4.8%) i3, and 6 (2.9%) i4. One hundred ninety-one patients had an RS of i0 to i2 and were included in the analyses for recurrent surgery. One hundred forty-nine patients had a second endoscopic evaluation and were included in the analysis for the primary outcome of endoscopic disease progression. Kaplan-Meier analyses were performed and found the hazard ratio (HR) of endoscopic progression to be significantly higher with i2b lesions when compared with i0 or i1 (HR, 6.22; 95% confidence interval [CI], 2.38-16.2; P = .0008). Patients with i2a did not have significantly higher rates of endoscopic progression when compared with i0 or i1 (HR, 2.30; 95% CI, .80-6.66; P = .12). Likewise, patients with i2b lesions had higher risk of needing recurrent surgery when compared with i0 or i1 (HR, 3.64; 95% CI, 1.10-12.1; P = .034), whereas patients with i2a lesions were not found to have a significantly elevated risk of recurrent surgery (HR, 1.43; 95% CI, .35-5.77; P = .62). CONCLUSION: Endoscopic lesions limited to the ileocolonic anastomosis (RS i2a) in patients with CD undergoing colonoscopy within 1 year of their resection were not associated with a significantly higher rate of progression to more severe disease, whereas those in the neoileum (RS i2b) were. Prospective studies are needed to confirm these findings.
引用
- Ollech JE, Aharoni-Golan M, Weisshof R, et al. Differential risk of disease progression between isolated anastomotic ulcers and mild ileal recurrence after ileocolonic resection in patients with Crohn's disease. Gastrointest Endosc. 2019. PMID: 30738034. doi:10.1016/j.gie.2019.01.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。